Johnson & Johnson

Pharmaceutical Research & Development LLC, Raritan, NJ

Vice President, Central Planning                                                             2001– 2004

Led a global organization to provide transparent information, systems and support for drug development project teams, clinical and non-clinical functions and executive management. Achieved a common goal of aggressively executing projects within the approved resources, with acceptable risks, in order to maximize the overall value of the J&JPRD portfolio and its strategic fit with the Pharmaceutical Group’s objectives.

·          Executive sponsor/leader of a $5M J&J Pharma Enterprise Resource/Project Management system. Brought over 100 global colleagues together, utilized a 3-day “Accelerated Solutions Environment” to gain unanimous alignment of goals, selection criteria and process to select the tool.

·          Selected as the Global Process Owner for business planning in implementing an SAP system. Partnered with Finance to align planning, resource, HR and financial systems and deliver a new system on schedule and on budget in 12 months.

·          Together with the head of clinical operations, analyzed the business needs and jointly developed a real-time process and system to evaluate and execute the optimal approach to managing a large number of multi-site, multi-country clinical trials.  This resulted in line managers gaining the ability to see their clinical trial and resource capacity real time and optimize their country specific responsibilities.

·          Reduced operating costs by over $1M annually by implementing common resource management and planning approaches.  Received company wide recognition for one of the most successful collaborations with pre-clinical drug evaluation group, commercial operating companies and medical affairs to standardize resource management and project planning approaches.

·          Improved Customer service ratings by over 50%. Created and maintained service level agreements (SLA’s) with drug development functions and therapeutic area teams, established service expectations and surveyed customers.

·          Coordinated and published reports throughout the organization regarding monthly project status, quarterly investor relations reports and ad hoc requests for project and metrics information.

·          Implemented radical new “Drug Development Intrasite” that provided instant access to drug development information including compound, project and portfolio level data.

·          Voting member of Project Management Stage Gate Review committee for all new compounds.

Johnson & Johnson                                                                                                                        2001– 2002

Pharmaceutical Research &Development LLC

New Product Development Leader –Project, Resource and Portfolio Management                          

Selected to lead a multi-company initiative in developing a New Product Development Process. Led the design team, implementation teams and continually improved the processes to systematically and proactively plan, manage and communicate project, resource and portfolio information in an integrated way. Met weekly with J&J Pharma’s “Global Operating Committee” to review our progress and gain agreement on the design elements.

·          Led a team of drug development and commercial team members to design a new approach to managing J&J’s Drug Development process. The core design is being expanded to other recent J&J acquisitions and the model of how to do business.

·          Developed a “Deliverable Based” resource management system designed around standardized algorithms, complexity factors and scheduling anchor points.  The resulting approach continues to provide J&J with faster analysis and alignment of data in managing the business of drug development.

·          Created a drug development contract and contracting process between the therapeutic areas, functions and senior management. The contract process has increased the level of trust in the organization and provides an objective means to measure performance of the drug development organization.

·          Developed an “Integrated Project Plan” combining many disparate and obsolete documents.

·          Received J&J “Standards of Leadership” award in 2002 for leadership in designing J&J PRD’s New Product Development process.

·          Based on successful design efforts, selected to lead a cross company implementation team focused on Project and Resource management. 

Copyright © 2004 [Peter S Benton]